Microbot Medical
MBOT
33 hedge funds and large institutions have $11.1M invested in Microbot Medical in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 9 closing their positions.
7.01% less ownership
Funds ownership: 17.32% → 10.31% (-7%)
18% less funds holding
Funds holding: 40 → 33 (-7)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
75% less capital inflows, than outflows
Capital inflows: $418K | Capital outflows: $1.67M
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$213K |
| 2 |
Bourgeon Capital Management
Darien,
Connecticut
|
+$85.7K |
| 3 |
BlackRock Institutional Trust
San Francisco,
California
|
+$75K |
| 4 |
Two Sigma Securities
New York
|
+$19.6K |
| 5 |
M&T Bank
Buffalo,
New York
|
+$8.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.25M |
| 2 |
Virtu KCG Holdings
New York
|
-$94.7K |
| 3 |
D.E. Shaw & Co
New York
|
-$78.6K |
| 4 |
Renaissance Technologies
New York
|
-$45K |
| 5 |
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$37K |
MBOT Hedge Fund Activity: Q1 2015 in Review
33 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2015, worth a combined $11.1M — down 2% from $11.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MBOT and 2 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $213K. The largest seller was Sabby Management, cutting an estimated $1.25M.
- 33 institutional investors held Microbot Medical (MBOT) as of Q1 2015, down from 40 in Q4 2014.
- Funds reported $11.1M of Microbot Medical stock for Q1 2015, down 2% quarter-over-quarter.
- 2 funds opened new Microbot Medical positions in Q1 2015 and 9 closed out, a net change of -7 holders.
- The largest Microbot Medical buyer in Q1 2015 was Vanguard Group, an estimated $213K added.
- The largest Microbot Medical seller in Q1 2015 was Sabby Management, an estimated $1.25M sold.
Based on aggregated 13F filings for Q1 2015.